What AI agents think about this news
CoreWeave's massive backlog and recent deals like Anthropic signal growth potential, but high debt, negative earnings, and execution risks, including counterparty risk and power bottlenecks, make it a high-stakes bet.
Risk: Counterparty risk and power bottlenecks could turn the $66.8B backlog into a liability and idle GPUs, respectively.
Opportunity: The Anthropic deal and other recent deals signal real demand and diversification, potentially unlocking scale and operating leverage.
Artificial intelligence (AI) is fast becoming an infrastructure race, and CoreWeave (CRWV) has found itself right in the middle of it. The company, which started out in crypto, now runs cloud systems built to handle heavy AI workloads, helping businesses scale quickly as demand for computing power surges.
That rising demand is now showing up in big deals. CoreWeave recently signed a multi-year data center agreement with Anthropic to support its Claude AI models. The plan is to roll out additional compute capacity over time, using advanced chips from Nvidia (NVDA) across U.S. facilities. The news gave the stock a lift, as investors took it as another sign that CoreWeave is becoming a key player in the AI buildout.
The backdrop makes it even more interesting. Anthropic, backed by giants like Amazon (AMZN) and Alphabet (GOOG) (GOOGL), is scaling aggressively, and its partnership adds credibility to CoreWeave’s platform. Plus, timing is adding to the momentum. On Apr. 9, Meta Platforms (META) expanded its own AI deal with the company, pointing to strong demand from big tech clients.
With deals stacking up and AI spending still on the rise, CoreWeave seems to be in a sweet spot. But after the recent run-up, does this Anthropic deal still make the stock worth buying now?
About CoreWeave Stock
CoreWeave, founded in 2017 and headquartered in Livingston, New Jersey, has rapidly established itself as a leader in GPU-optimized cloud infrastructure. With a market capitalization of $46.2 billion, the company supports the accelerating AI revolution through systems designed for generative AI and large-scale compute workloads. Its mission is to streamline modern AI complexity and empower enterprises to deploy intelligence at scale, positioning CoreWeave as a foundational pillar of next-generation technology.
CRWV stock has been riding the same wave as the broader AI trade – fast up, sharp down, and never boring. The company went public in March 2025 at $40 and quickly caught fire, rallying to a high of $187 by June 20. That surge was fueled by a string of AI cloud deals, partnerships, acquisitions, and even a push into federal contracts, putting CoreWeave firmly on investors’ radar.
But the ride has not been smooth. The stock has since pulled back and now trades $117, still well above its 52-week low of $33.51, but about 37% below its peak. Volatility showed up again when the company issued weaker-than-expected Q1 2026 guidance on Feb. 27, triggering an 18.5% single-day drop, reminding investors how sensitive high-growth AI names can be to outlook changes.
Even then, the bigger trend remains strong. CRWV is still up 170.65% over the past 52 weeks and 64.82% year-to-date (YTD). Momentum has picked up sharply in recent weeks, with the stock rising 45.52% in a month and over 38.47% in just the past five days, largely driven by the Anthropic deal news.
Technically, trading volumes are rising, signaling strong buying interest, while the 14-day RSI has moved into overbought territory at 74.52, suggesting the rally may be running a bit hot in the near term.
Even after the pullback, CoreWeave isn’t cheap, priced at 4.66 times forward sales. The market is clearly pricing in aggressive AI-driven growth and a long runway ahead, leaving little room for execution missteps.
CoreWeave Stock Gets a Broader Backing with Anthropic Deal
CoreWeave was growing fast, but much of that growth leaned heavily on a few large customers. The agreement with Anthropic begins to ease that dependence and signals a more diversified growth path.
This partnership shows that demand for CoreWeave’s infrastructure is widening. By bringing in another major AI player, the company is steadily building a more balanced and resilient business model. It is no longer just about landing big deals – it’s about who those deals are coming from.
Plus, the move reinforces CoreWeave’s credibility in a highly competitive space. Winning over advanced AI labs signals that its platform can meet the growing needs of cutting-edge model development. For investors, that shifts the view from customer concentration risk to a wider growth opportunity.
CoreWeave Reports Mixed 2025 Results
CoreWeave’s latest results show a company scaling rapidly with the AI boom. In the fourth quarter of 2025, the company delivered a top-line beat, with revenue hitting $1.57 billion, up 110% year-over-year (YOY), driven by surging GPU demand from hyperscalers like Microsoft (MSFT) and OpenAI. For fiscal 2025, revenue reached $5.1 billion, marking an impressive 168% annual growth.
But this is a growth-at-all-costs phase. CoreWeave reported an adjusted net loss of $606 million for the year, as it continues to invest heavily to scale. Still, profitability at the operating level showed strength, with adjusted EBITDA more than doubling to $3.1 billion and margins touching 60%. Even more striking, its backlog surged to $66.8 billion – over four times higher than last year – offering strong visibility into future revenue.
The company is clearly building ahead of demand. In Q4 alone, capital expenditures hit $8.2 billion, taking the full-year total to $14.9 billion. That’s higher than expected, but reflects its ability to bring infrastructure online faster. It added 260 megawatts of active power in Q4 across 43 data centers, with active power capacity totaling 850 megawatts. However, this rapid expansion is also pushing up costs, with operating expenses rising to $1.66 billion and interest expenses climbing to $388 million due to higher debt.
To support this scale-up, CoreWeave has been actively strengthening its balance sheet. It ended 2025 with $4.2 billion in cash, cash equivalents, restricted cash and marketable securities, and raised $2.6 billion through convertible notes, while expanding its credit facility to $2.5 billion. Overall, it secured more than $18 billion in capital during the year, backed by over 200 investment partners and financial institutions.
Looking ahead, the management has set a cautious tone for the near term, even as the long-term story remains strong. For Q1, revenue is expected to be between $1.9 billion and $2 billion, slightly below market expectations. Margins are also expected to be under pressure, with adjusted operating income projected in the range of $0 to $40 million. Management has made it clear that Q1 will likely be the lowest point for margins this year.
The reason is simple – CoreWeave is still in heavy build-out mode. It plans to deploy $6 billion to $7 billion in infrastructure in just Q1, continuing to bring large amounts of new capacity online. As CFO Nitin Agrawal explained, margins should gradually improve through the year, returning to low double-digit levels by Q4 as new capacity starts generating revenue.
For the full year 2026, the company expects revenue to reach between $12 billion and $13 billion. At the same time, it plans a massive $30 billion to $35 billion in capital spending, more than double last year’s levels. Importantly, management noted that almost all of this spending is backed by already signed customer contracts, giving strong visibility into future growth. Adjusted operating income for the year is expected to come in between $900 million and $1.1 billion, reflecting both scale and improving efficiency over time.
CEO Mike Intrator didn’t sugarcoat the situation, making it clear on the earnings call that “Our margins reflect the cost of building tomorrow’s revenues.”
Analysts tracking CoreWeave anticipate fiscal 2026 revenue to be around $12.4 billion, while losses are expected to continue, pegged at -$4.16 per share, widening by 54.7% YOY. The turnaround might start showing in fiscal 2027, when losses are expected to shrink by 8.9% annually and come down to -$3.79 per share.
What Do Analysts Expect for CoreWeave Stock?
DA Davidson remains positive on CoreWeave, raising its price target to $175 from $125 while keeping a “Buy” rating. The brokerage firm points to the recent Anthropic deal and expanded Meta Platforms partnership as signs that CoreWeave is becoming a preferred cloud provider for leading AI labs driving future compute demand.
The consensus rating on CRWV stock remains at “Moderate Buy.” Among 32 analysts covering the stock now, 19 advise a “Strong Buy,” one suggests a “Moderate Buy,” 11 analysts are playing it safe with a “Hold” rating, and the remaining one analyst remains skeptical with a “Strong Sell.”
Even with the stock sliding, analysts are bullish. The stock has already surpassed the average price target of $117.43, and the Street-high target of $180 suggests that the stock could rise as much as 52.8%.
On the date of publication, Sristi Suman Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
AI Talk Show
Four leading AI models discuss this article
"CoreWeave’s $66.8 billion backlog provides enough revenue visibility to justify its aggressive, debt-financed capital expenditure cycle through 2026."
CoreWeave’s $66.8 billion backlog is the real story, not just the Anthropic headline. While the market obsesses over the 'AI infrastructure race,' CoreWeave is effectively acting as a high-beta proxy for Nvidia’s supply chain. Trading at 4.66x forward sales is reasonable for a company growing revenue at triple digits, provided the $30B+ in planned 2026 CapEx doesn't hit a wall. The shift from crypto-roots to enterprise-grade cloud provider is impressive, but the massive debt load and negative EPS suggest we are betting on their ability to execute perfectly in a capital-intensive environment. I see this as a 'buy' for growth-oriented portfolios, but with a strict eye on interest coverage ratios.
The company is essentially a massive, debt-fueled pass-through entity for Nvidia hardware; if GPU supply constraints ease or if hyperscalers like Microsoft build out their own internal capacity, CoreWeave’s margins will be crushed by its own astronomical interest expenses.
"CRWV's capex explosion to $30-35B in 2026 (vs $12-13B rev) risks dilution or covenant breaches if AI hype cools, even with the Anthropic win."
CoreWeave's Anthropic deal adds a marquee name, easing some customer concentration worries (top clients still dominate ~80% implied from past), but the stock's 37% peak-to-trough drop post-IPO highlights execution risks. At $117/share and $46B mcap, 4.66x 2026 fwd sales ($12-13B rev guidance) looks frothy for a firm projecting -$4.16 EPS (losses widening 55% YoY) amid $30-35B capex (2.5x rev) and $388M interest expense. Q1 2026 guidance miss already triggered 18% plunge; RSI 74 screams overbought. Hyperscalers (MSFT, AMZN) building in-house capex could cap CRWV's TAM long-term.
A $66.8B backlog (4x YoY, contract-backed) provides ironclad multi-year visibility into $12B+ rev, justifying capex to capture insatiable AI GPU demand from labs like Anthropic outpacing hyperscaler buildouts.
"CoreWeave's customer diversification is real, but it masks the core issue: the company is trading on backlog visibility while margins compress to near-zero in the near term, leaving minimal margin of safety for any capex delays, power constraints, or customer pushback on pricing."
CoreWeave's Anthropic deal is real validation, but the article conflates *customer diversification* with *margin safety*. Yes, adding Anthropic reduces concentration risk—that's genuine. But the core problem remains: CoreWeave is burning $606M annually on $5.1B revenue while deploying $30–35B capex in 2026 alone. The backlog ($66.8B) looks impressive until you realize it's mostly pre-contracted capex, not margin expansion. The company is essentially a leveraged bet on sustained hyperscaler spending. Q1 2026 guidance (near-zero operating income on $1.9–2B revenue) shows margins are collapsing *during* the buildout, not improving. At 4.66x forward sales with negative earnings, you're paying for flawless execution across three years.
If CoreWeave's backlog is 90%+ contracted and power utilization ramps as promised, the margin cliff is temporary—Q4 2026 guidance of $900M–$1.1B operating income on ~$13B revenue would justify current multiples. The real risk isn't the Anthropic deal; it's whether execution matches the $30–35B capex plan.
"Anthropic and Meta commitments, plus a $66.8B backlog, imply durable demand that could drive real revenue growth and margin recovery if execution stays on plan."
CRWV is riding the AI infra wave, with Anthropic and Meta deals signaling real demand and diversification beyond a handful of customers. 2025 revenue of $5.1B and a $66.8B backlog suggest strong visibility, while a plan to spend $30-35B in 2026 could unlock scale and operating leverage if capacity comes online on time. However, the model is still cash-burning, with negative net income in 2025 and a heavy debt/load that makes margins highly rate- and execution-sensitive. Valuation at ~4.7x forward sales leaves room for upside, but any slowdown in AI demand, supply-chain constraints, or tightening financing could snap the multiple back to earth.
Backlog and revenue visibility could be overstated, as large deals can slip or cancel; and the massive capex plan makes the business extremely sensitive to demand turns and financing costs, which could derail profitability before scale is achieved.
"The $66.8B backlog creates severe counterparty and asset-impairment risk if AI lab funding or model architectures shift."
Claude, you hit the nail on the head regarding the 'margin cliff,' but everyone is ignoring the counterparty risk inherent in these massive, long-term contracts. If Anthropic or similar labs face a funding crunch or pivot their model architecture away from GPU-heavy training, CoreWeave’s $66.8B backlog becomes a liability, not an asset. They are essentially a massive, illiquid warehouse of depreciating hardware. If utilization rates drop, they lack the balance sheet flexibility to pivot.
"US power grid constraints create an unmentioned execution risk that could strand billions in CoreWeave's capex."
Gemini flags counterparty risk aptly, but everyone's missing the power bottleneck: CoreWeave's $30-35B capex requires 2-3GW+ capacity amid US grid delays (5-10yr substation queues). Recent PJM alerts highlight AI data center rationing; failed PPAs could idle 30%+ of new GPUs, turning backlog into $10B+ stranded capex before utilization even starts. This trumps debt—execution dies without electrons.
"Power bottlenecks delay margins but don't invalidate backlog if CoreWeave can rent interim capacity."
Grok's power constraint is the linchpin everyone underweighted. CoreWeave's $30–35B capex is meaningless without grid access; PJM queues aren't a 2026 problem—they're a 2027–2028 wall. But here's what Grok missed: CoreWeave can lease existing data center capacity (AWS, Equinix) while power infrastructure catches up. This delays margin expansion but doesn't crater the backlog. The real question: can they monetize contracted GPU capacity via third-party power before their own infrastructure comes online?
"Leasing capacity and energy markets can de-risk the capex burn, so grid constraints are tail-risk rather than a knockout for CoreWeave."
Responding to Grok: The power bottleneck is real, but you overstate the near-term capex-to-grid urgency. CoreWeave can de-risk by leasing capacity and using energy markets to monetize idle GPUs while the in-house build-out catches up; that reduces immediate stranded-capex risk. The bigger issue is economics: GPU ASPs and utilization ramps into 2027–28 matter more than 2026 grid constraints. Grid risk is tail-risk, not a knockout.
Panel Verdict
No ConsensusCoreWeave's massive backlog and recent deals like Anthropic signal growth potential, but high debt, negative earnings, and execution risks, including counterparty risk and power bottlenecks, make it a high-stakes bet.
The Anthropic deal and other recent deals signal real demand and diversification, potentially unlocking scale and operating leverage.
Counterparty risk and power bottlenecks could turn the $66.8B backlog into a liability and idle GPUs, respectively.